COOPER COMPANIES INC
8-K, 1999-02-05
OPHTHALMIC GOODS
Previous: COOPER COMPANIES INC, DEF 14A, 1999-02-05
Next: GALILEO CORP, 8-K, 1999-02-05







<PAGE>
 <PAGE>


================================================================================


                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported): January 27, 1999

                           THE COOPER COMPANIES, INC.

             (Exact name of registrant as specified in its charter)


<TABLE>
<S>                              <C>                             <C>
         Delaware                             1-8597                            94-2657368
(State or other jurisdiction          (Commission File Number)       (IRS Employer Identification No.)
      of incorporation)
</TABLE>

       6140 Stoneridge Mall Road, Suite 590, Pleasanton, California 94588
                    (Address of principal executive offices)

                                 (925) 460-3600
              (Registrant's telephone number, including area code)

================================================================================




<PAGE>
 <PAGE>


ITEM 5. OTHER EVENTS.

On January 27, 1999, The Cooper Companies, Inc. (the "Company") issued a press
release announcing it expects first quarter revenue shortfall. This release is
filed as an exhibit hereto and is incorporated by reference herein.

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.

               (c) Exhibits.

<TABLE>
<CAPTION>
Exhibit
  No.          Description
- -------        -----------
<S>           <C>
99.1           Press Release dated January 27, 1999 of The Cooper Companies, Inc.
</TABLE>



<PAGE>
 <PAGE>



                                    SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                             THE COOPER COMPANIES, INC.

                                             By   /s/ Stephen C. Whiteford
                                                 --------------------------
                                                 Stephen C. Whiteford
                                                 Vice President and
                                                 Corporate Controller
                                                 (Principal Accounting Officer)

Dated:  February 3, 1999



<PAGE>
 <PAGE>



                                  EXHIBIT INDEX


<TABLE>
<CAPTION>

Exhibit                                                                 Sequentially
  No.          Description                                              Numbered Page
- -------        -----------                                              -------------
<S>           <C>                                                     <C>
99.1           Press Release dated January 27, 1999 of The Cooper
               Companies, Inc.
</TABLE>



<PAGE>









<PAGE>


CONTACT:

Norris Battin
The Cooper Companies, Inc.
E-mail: [email protected]

FOR IMMEDIATE RELEASE

                 COOPER EXPECTS FIRST QUARTER REVENUE SHORTFALL

IRVINE, Calif. January 27, 1999 - The Cooper Companies, Inc., (NYSE/PCX:COO)
today announced it expects that revenue in its 1999 fiscal first quarter ending
January 31 will fall short of analysts' estimates due primarily to lower than
anticipated sales of its CooperVision contact lens business unit. CooperVision's
first quarter revenue is expected to be about $28 million. Although the
Company's current estimates indicate that Toric planned replacement lenses will
grow by over 40% and total CooperVision revenue 22% over the prior year's first
quarter, overall revenue will not achieve the consensus estimate. The revenue
shortfall will result in earnings per share from continuing operations of
approximately twenty-seven to thirty cents before taxes and an after tax range
of about sixteen to eighteen cents. Both of these ranges would be below
consensus estimates.

A. Thomas Bender, president and CEO of Cooper said, "Revenue will fall below
expectations because we cannot yet offer a full range of lens parameters for our
Frequency'r'55 and Frequency'r'55 Toric products. In this situation, our sales
force cannot fully leverage our promotional efforts for these product lines. The
Company expects to resolve these production delays by the end of the second
quarter, leading to improved results throughout the year."

Cooper expects to release its first quarter earnings on February 23, 1999.

Forward-Looking Statements

Statements in this release not based on historical fact may be "forward-looking
statements" as defined by the Private Securities Litigation Reform Act of 1995.
They include words like "may," "will," "expect," "anticipate," "continue" or
similar terms and reflect Cooper's current analysis of existing trends. Actual
results could differ materially from those indicated due to: major changes in
business conditions and the economy, loss of key senior management, major
disruptions in the operations of Cooper's manufacturing facilities, new
competitors or technologies, significant disruptions caused by the failure of
third parties to address the Year 2000 issue or by unforeseen delays in
completing Cooper's Year 2000 compliance program, acquisition integration costs,
foreign currency exchange exposure including the potential impact of the Euro,
investments in research and development and other start-up projects, dilution to
earnings per share from acquisitions or issuing stock, regulatory issues,
changes in



<PAGE>
 <PAGE>



reimbursement rates and payor mix, significant environmental clean-up costs
above those already accrued, litigation costs, costs of divestitures,
significant delay or failure to complete the sale of Hospital Group of America,
and items listed in the Company's SEC reports, including the section entitled
"Business" in its Annual Report on Form 10-K for the year ended October 31,
1997.

The Cooper Companies, Inc. and its subsidiaries develop, manufacture and market
specialty healthcare products and services. Corporate offices are in Irvine and
Pleasanton, Calif. CooperVision, Inc. markets a broad range of contact lenses
for the vision care market. It is headquartered in Irvine, Calif., with
manufacturing facilities in Huntington Beach, Calif., Rochester, N.Y., Toronto,
Canada and Hampshire, England. CooperSurgical, headquartered in Shelton, Conn.,
markets diagnostic products and surgical instruments and accessories for the
women's healthcare market.

NOTE: A toll free interactive telephone system at 1-800-334-1986 provides stock
quotes, recent releases and financial data. The Cooper Company's Internet
address is www.coopercos.com




                            STATEMENT OF DIFFERENCES

   The registered trademark symbol shall be expressed as....................'r'

<PAGE>





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission